Hisamitsu Pharmaceutical Co (TSE:4530) Long-Term Debt : 円95 Mil (As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Long-Term Debt?

Hisamitsu Pharmaceutical Co's Long-Term Debt for the quarter that ended in Nov. 2023 was 円95 Mil.

Hisamitsu Pharmaceutical Co's quarterly Long-Term Debt declined from May. 2023 (円131 Mil) to Aug. 2023 (円112 Mil) and declined from Aug. 2023 (円112 Mil) to Nov. 2023 (円95 Mil).

Hisamitsu Pharmaceutical Co's annual Long-Term Debt declined from Feb. 2022 (円219 Mil) to Feb. 2023 (円147 Mil) and declined from Feb. 2023 (円147 Mil) to Feb. 2024 (円76 Mil).

Hisamitsu Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Long-Term Debt Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Long-Term Debt

Get a 7-Day Free Trial

368.00

296.00

219.00

147.00

76.00

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Long-Term Debt	Get a 7-Day Free Trial															147.00	131.00	112.00	95.00	76.00

Hisamitsu Pharmaceutical Co (TSE:4530) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Hisamitsu Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines